 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 03/21/2023 |
$0.87 |
$0.90 |
$0.79 |
$0.79 |
508.80K | | 03/22/2023 |
$0.77 |
$0.79 |
$0.70 |
$0.75 |
489.90K | | 03/23/2023 |
$0.81 |
$0.81 |
$0.75 |
$0.77 |
116.40K | | 03/24/2023 |
$0.77 |
$0.80 |
$0.74 |
$0.75 |
122.30K | | 03/27/2023 |
$0.77 |
$0.78 |
$0.71 |
$0.76 |
149.90K |
|
|
| Acer Therapeutics is a pharmaceutical company focused on the acquisition, development, and commercialization of therapies for rare and life-threatening diseases. Co.'s pipeline includes four programs: ACER-001 (sodium phenylbutyrate) for the treatment of various inborn errors of metabolism, including urea cycle disorders and Maple Syrup Urine Disease; ACER-801 (osanetant) for the treatment of induced vasomotor symptoms; EDSIVO™ (celiprolol) for the treatment of vascular Ehlers-Danlos syndrome in patients with a confirmed type III collagen mutation; and ACER-2820 (emetine), a host-directed therapy against a variety of viruses, including cytomegalovirus, zika, dengue, ebola and COVID-19. | |
|
Acer Therapeutics (ACER) has the following price history information. Looking back at ACER historical stock prices for the last five trading days, on March 21, 2023, ACER opened at $0.87, traded as high as $0.90 and as low as $0.79, and closed at $0.79. Trading volume was a total of 508.80K shares. On March 22, 2023, ACER opened at $0.77, traded as high as $0.79 and as low as $0.70, and closed at $0.75. Trading volume was a total of 489.90K shares. On March 23, 2023, ACER opened at $0.81, traded as high as $0.81 and as low as $0.75, and closed at $0.77. Trading volume was a total of 116.40K shares. On March 24, 2023, ACER opened at $0.77, traded as high as $0.80 and as low as $0.74, and closed at $0.75. Trading volume was a total of 122.30K shares. On March 27, 2023, ACER opened at $0.77, traded as high as $0.78 and as low as $0.71, and closed at $0.76. Trading volume was a total of 149.90K shares.
ACER Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acer Therapeutics shares, starting with a $10,000 purchase of ACER, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/01/2013 |
|
| End date: |
03/27/2023 |
|
| Start price/share: |
$23.02 |
|
| End price/share: |
$0.76 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-96.70% |
|
| Average Annual Total Return: |
-28.92% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$330.14 |
|
| Years: |
9.99 |
|
|
|
| Date |
Close |
| 03/21/2023 | $0.79 | | 03/22/2023 | $0.75 | | 03/23/2023 | $0.77 | | 03/24/2023 | $0.75 | | 03/27/2023 | $0.76 |
|
|
Free ACER Email Alerts:
